カテゴリ： GlobalData, 企業調査

Exosome Diagnostics Inc：企業の製品パイプライン分析

◆英語タイトル：Exosome Diagnostics Inc - Product Pipeline Analysis, 2020 Update
◆商品コード：GDME103113PD
◆発行会社（調査会社）：GlobalData
◆発行日：2021年1月
◆ページ数：49
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Medical Devices
◆販売価格オプション（消費税別）
Site License（同一事業所内共有可）USD1,500 ⇒換算￥195,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥292,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer’s disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Exosome Diagnostics Inc Company Overview
Exosome Diagnostics Inc Company Snapshot
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Exosome Diagnostics Inc – Pipeline Analysis Overview
Exosome Diagnostics Inc – Key Facts
Exosome Diagnostics Inc – Major Products and Services
Exosome Diagnostics Inc Pipeline Products by Development Stage
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc Pipeline Products Overview
Biofluid Nucleic Acid Kit – Alzheimer’s Disease
Biofluid Nucleic Acid Kit – Alzheimer’s Disease Product Overview
Biofluid Nucleic Acid Kit – Cardiovascular Disease
Biofluid Nucleic Acid Kit – Cardiovascular Disease Product Overview
Biofluid Nucleic Acid Kit – Chronic Kidney Disease
Biofluid Nucleic Acid Kit – Chronic Kidney Disease Product Overview
Biofluid Nucleic Acid Kit – Parkinson’s Disease
Biofluid Nucleic Acid Kit – Parkinson’s Disease Product Overview
Biofluid-Based Molecular Diagnostic Test – Brain Cancer
Biofluid-Based Molecular Diagnostic Test – Brain Cancer Product Overview
BIONIC Liquid Biopsy – Bladder Cancer
BIONIC Liquid Biopsy – Bladder Cancer Product Overview
Diagnostic Assay – Arv7
Diagnostic Assay – Arv7 Product Overview
Diagnostic Assay – Arv7 Clinical Trial
Diagnostic Assay – BRAF
Diagnostic Assay – BRAF Product Overview
Diagnostic Assay – Breast Cancer Signature
Diagnostic Assay – Breast Cancer Signature Product Overview
Diagnostic Assay – IDH1
Diagnostic Assay – IDH1 Product Overview
Diagnostic Assay – Kidney Transplant Rejection
Diagnostic Assay – Kidney Transplant Rejection Product Overview
Diagnostic Test – Parkinson’s Disease
Diagnostic Test – Parkinson’s Disease Product Overview
EGFR 29 Mutation Panel
EGFR 29 Mutation Panel Product Overview
ExoDx Lung(T790M)
ExoDx Lung(T790M) Product Overview
ExoDx Lung(T790M) Clinical Trial
ExoDx Prostate(IntelliScore) – IVD Version
ExoDx Prostate(IntelliScore) – IVD Version Product Overview
ExoDx Prostate(IntelliScore) – IVD Version Clinical Trial
Midi Lung Cancer Panel
Midi Lung Cancer Panel Product Overview
Next-Generation Solid Tumor Mutation Panel
Next-Generation Solid Tumor Mutation Panel Product Overview
Shahky
Shahky Product Overview
Exosome Diagnostics Inc – Key Competitors
Exosome Diagnostics Inc – Key Employees
Exosome Diagnostics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exosome Diagnostics Inc, Recent Developments
Oct 10, 2019: Medicare issues final local coverage decision for bio-Techne’s ExoDx Prostate(IntelliScore) Test
Jun 17, 2019: FDA grants breakthrough device designation to Bio-Techne’s ExoDx Prostate IntelliScore (EPI) Test
Jun 13, 2019: Bio-Techne receives approval to offer The ExoDx Prostate Intelliscore (EPI) test in New York State
Sep 18, 2018: Bio-Techne announces publication of data demonstrating additional clinical validation of its EPI Test in European Urology Journal
Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel
May 17, 2018: Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA
May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain
May 09, 2018: Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Exosome Diagnostics Inc Pipeline Products by Equipment Type
Exosome Diagnostics Inc Pipeline Products by Indication
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc, Key Facts
Exosome Diagnostics Inc, Major Products and Services
Exosome Diagnostics Inc Number of Pipeline Products by Development Stage
Exosome Diagnostics Inc Pipeline Products Summary by Development Stage
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status
Exosome Diagnostics Inc Ongoing Clinical Trials Summary
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description
BIONIC Liquid Biopsy - Bladder Cancer - Product Status
BIONIC Liquid Biopsy - Bladder Cancer - Product Description
Diagnostic Assay - Arv7 - Product Status
Diagnostic Assay - Arv7 - Product Description
Diagnostic Assay - Arv7 - Detection of ARv7 in the Plasma of Men with Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Diagnostic Assay - BRAF - Product Status
Diagnostic Assay - BRAF - Product Description
Diagnostic Assay - Breast Cancer Signature - Product Status
Diagnostic Assay - Breast Cancer Signature - Product Description
Diagnostic Assay - IDH1 - Product Status
Diagnostic Assay - IDH1 - Product Description
Diagnostic Assay - Kidney Transplant Rejection - Product Status
Diagnostic Assay - Kidney Transplant Rejection - Product Description
Diagnostic Test - Parkinson's Disease - Product Status
Diagnostic Test - Parkinson's Disease - Product Description
EGFR 29 Mutation Panel - Product Status
EGFR 29 Mutation Panel - Product Description
ExoDx Lung(T790M) - Product Status
ExoDx Lung(T790M) - Product Description
ExoDx Lung(T790M) - Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients
ExoDx Prostate(IntelliScore) - IVD Version - Product Status
ExoDx Prostate(IntelliScore) - IVD Version - Product Description
ExoDx Prostate(IntelliScore) - IVD Version - A Prospective, Randomized Blinded, Shared Decision Impact Trial of the ExoDx Prostate (IntelliScore), EPI Test, in Men Presenting for Initial Biopsy
ExoDx Prostate(IntelliScore) - IVD Version - Clinical Evaluation of ExoDx Prostate (IntelliScore) in Men with Prior Negative Prostate Biopsy Presenting for a Repeat Biopsy
Midi Lung Cancer Panel - Product Status
Midi Lung Cancer Panel - Product Description
Next-Generation Solid Tumor Mutation Panel - Product Status
Next-Generation Solid Tumor Mutation Panel - Product Description
Shahky - Product Status
Shahky - Product Description
Exosome Diagnostics Inc, Key Employees
Exosome Diagnostics Inc, Subsidiaries
Glossary

★海外企業調査レポート[Exosome Diagnostics Inc：企業の製品パイプライン分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Doosan Heavy Industries & Construction Co Ltd (034020)-エネルギー分野：企業M&A・提携分析
    Summary Doosan Heavy Industries & Construction Co., Ltd. (Doosan Heavy Industries), a subsidiary of Doosan Corporation, is a power plant equipment manufacturer. It offers integrated equipment and solutions for power and water plants. The company’s major products include boilers, generators, engines, …
  • BB&T Corporation：企業のM&A・事業提携・投資動向
    BB&T Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BB&T Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Accuray Inc (ARAY)：製品パイプライン分析
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • Baker Hughes Incorporated：企業の戦略・SWOT・財務情報
    Baker Hughes Incorporated - Strategy, SWOT and Corporate Finance Report Summary Baker Hughes Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bio-Rad Laboratories Inc (BIO)：医療機器：M&Aディール及び事業提携情報
    Summary Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics …
  • Tulip Star Hotels Limited：企業の戦略・SWOT・財務分析
    Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ono Pharmaceutical Co Ltd (4528)：医療機器：M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • Triple-S Management Corp (GTS)：企業の財務・戦略的SWOT分析
    Triple-S Management Corp (GTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Swiss Federal Railways：企業の戦略的SWOT分析
    Swiss Federal Railways - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Nippon Sheet Glass Co Ltd：戦略・SWOT・企業財務分析
    Nippon Sheet Glass Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • American Blue Ribbon Holdings LLC：企業の戦略・SWOT・財務分析
    American Blue Ribbon Holdings LLC - Strategy, SWOT and Corporate Finance Report Summary American Blue Ribbon Holdings LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Aragen Bioscience Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc, is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process d …
  • CSS Industries, Inc. (CSS)：企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Abcam Plc (ABC)：医療機器：M&Aディール及び事業提携情報
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • Spectrum Health System：企業の戦略的SWOT分析
    Spectrum Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Mallinckrodt, LLC-製薬・医療分野：企業M&A・提携分析
    Summary Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imag …
  • Real Matters Inc (REAL)：企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Marksans Pharma Ltd (MARKSANS)-製薬・医療分野：企業M&A・提携分析
    Summary Marksans Pharma Ltd (Marksans Pharma) is a pharmaceutical company that develops, manufactures and markets branded formulations and generic products. The company offers contract research and manufacturing services. Its focus therapy segments comprise antibiotics, antidiabetic, anti-inflammato …
  • Intelligent InSites Inc：医療機器：M&Aディール及び事業提携情報
    Summary Intelligent InSites Inc (Insites) is a provider of real-time operational intelligence for the health care industry. The company offers implementation, training, technical support, product maintenance and solution services. Its solutions include additional end-user training, additional integr …
  • Histogen Inc-製薬・医療分野：企業M&A・提携分析
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen’s proprietary technologies are used in …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆